Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=59

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01492361-e80ebb8f",
        "title": "AMR101 vs Placebo: Composite of CV Death, Nonfatal MI (Including Silent MI), Nonfatal Stroke, Coronary Revascularization, or Unstable Angina Determined to be Caused by Myocardial Ischemia by Invasive / Non-invasive Testing and Requiring Emergent Hospitalization.",
        "summary": "705 of 4089 against 901 of 4090; risk difference -4.8 points, 95% interval -6.5 to -3.1; NCT01492361, A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin",
        "record": "/library/comparisons/NCT01492361-e80ebb8f",
        "nct_id": "NCT01492361",
        "kind": "outcome",
        "participants": 8179,
        "risk_difference": {
          "value": -0.04787960542955905,
          "lower": -0.06505435733955797,
          "upper": -0.030678485013301716
        },
        "group_1": "705 of 4,089",
        "group_2": "901 of 4,090",
        "difference": "-4.8 points",
        "interval": "-6.5 to -3.1",
        "trial_title": "A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin"
      },
      {
        "id": "NCT01492361-sae",
        "title": "AMR101 vs Placebo: serious adverse events",
        "summary": "1252 of 4089 against 1254 of 4090; risk difference -0.0 points, 95% interval -2.0 to 2.0; NCT01492361, A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin",
        "record": "/library/comparisons/NCT01492361-sae",
        "nct_id": "NCT01492361",
        "kind": "serious-adverse-events",
        "participants": 8179,
        "risk_difference": {
          "value": -0.0004141351266831461,
          "lower": -0.020389130477220033,
          "upper": 0.019561407143183825
        },
        "group_1": "1,252 of 4,089",
        "group_2": "1,254 of 4,090",
        "difference": "-0.0 points",
        "interval": "-2.0 to 2.0",
        "trial_title": "A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=60",
  "request_id": "tdCj1Y1jV4J3bvRi"
}